- About Us
- Nano-Social Network
- Nano Consulting
- My Account
April 15th, 2009
Researchers from California and Massachusetts have come up with a new type of non-toxic nanoparticle (NP) that is efficiently broken down and excreted by the kidneys once it has delivered its drug cargo to the target organ [Park, et al., Nat. Mater. (2009), doi: 10.1038/nmat2398].
There is already a significant amount of research on drug delivery using NPs, but some of these systems suffer from major drawbacks, such as the body's immediate rejection of NPs before they can deliver their payload, or biodegradability and toxicity of the NPs or their by-products. However, the use of NPs for drug delivery remains of major interest because these small bodies have some exceptional properties. NPs have a large specific capacity for loading drugs, they are easily detected while they are in the body, and they are retained by the blood stream long enough for them to reach their target and offload the drug.
|Related News Press|
News and information
Explaining how 2-D materials break at the atomic level January 20th, 2017
New active filaments mimic biology to transport nano-cargo: A new design for a fully biocompatible motility engine transports colloidal particles faster than diffusion with active filaments January 11th, 2017
GLOBALFOUNDRIES Expands Partner Program to Speed Time-to-Market of FDX™ Solutions: Increased support affirms FDXcelerator™ Program’s vital role in promoting broader deployment of GLOBALFOUNDRIES’ FDX™ portfolio December 15th, 2016
Infrared instrumentation leader secures exclusive use of Vantablack coating December 5th, 2016